Getting to Clinical Trial Diversity
Differing levels of trust in clinical trials information channels across diverse populations is examined in this research.
Anticipating Careless Responders in Survey Design and Analysis
Clinical trials must rely on internet surveys to incorporate the needs of industry and patients, but how can results be improved?
Current and Future Use of Real-World Data
Survey among readers evaluates the trajectory of RWD and how it can be more widely adopted.
Data Intermediaries/Software Can Speed the Usage of Real-World Data
Survey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.
The Real-World Data That Matters
Survey taken by pharma and CRO executives evaluates attributes of large datasets.
Improving Your Survey Data
Identifying careless responding to improve survey construction and results.
The Limited Future of Real-World Data
Survey among pharma and CRO executives evaluates current usage of RWD.
Site Perspectives on Clinical Trial Quality
A model to identify the services and resources sites need to conduct high-quality clinical trials.
Precision Medicine Deserves Precision Trial Optimization
Lagging indicators and superficial averages are increasingly replaced by sophisticated performance metrics and predictive analytics harnessing the power of big and small data.
Preventing Patient Centricity from Becoming a Fad
This three-step process can help managers accurately assess how patient-centric their trials really are.
Quality Drivers In Clinical Trial Conduct
Adopting scientific quality measurement that recognizes that clinical trials are a service will reap benefits.
Properly Assessing Quality in Clinical Trials
In early January, Novartis selected Qualcomm Life as a global digital health collaborator for its Trials of The Future program.
The Quality of Clinical Trials
This article is the first in a series of articles that will review the development and findings of the first scientific measurement of quality in clinical trials.
The Metrics Behind High Performing Study Startups
A two-phase statistical analysis identifies the key performance drivers in clinical trial startup.
High Performing Study Startups
Study startup underperformance and inefficiency has been a problem for executives who manage clinical research trials for decades.